{"name":"SciNeuro","slug":"scineuro","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPS1l4RjRBYTQxXzJFUEdHUWJxTXV6WTdBWW04MTN6NFM4STRHckRXdlBPZ0pXRGxpUldvQUtONmxrRnJEamRveWpWb3RfZzJsbk9oZjZqTnp0VGNBT3JUanAzWHZTUmFQdzg4TDZIYzZUOWxLbmNWMTF5NU83NGRkU3JRQW1XanhCX2tuUFRWakxSV1Mxak52cHN5TWozOFprcEdhODlnZ2dtX1ZpLXlabDNrNUk4OTlDUFFhXw?oc=5","date":"2026-02-02","type":"deal","source":"The Healthcare Technology Report.","summary":"SciNeuro and Novartis Sign Global Deal to Advance Alzheimer’s Antibody Program - The Healthcare Technology Report.","headline":"SciNeuro and Novartis Sign Global Deal to Advance Alzheimer’s Antibody Program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOLW9zNDJEMVpVaGFkbUVtYUhMenNRTTEwckZBVm1HX0lPS0t3dlFTb09COUNKbzdWOHRWazVvNlZSTWt2OW50N0ZaYW1IQWxqSGNFM2pkSUhJenlLVUhTSUY4LTRiamN2WVBPM1p1c0NvZDFZMFZPWkkxSERMNHJKSUx1YzNkMEpZRDhnWXAwVGE?oc=5","date":"2026-01-13","type":"deal","source":"Pharmaceutical Technology","summary":"JPM26: SciNeuro and Novartis sign global licensing deal for Alzheimer’s antibody - Pharmaceutical Technology","headline":"JPM26: SciNeuro and Novartis sign global licensing deal for Alzheimer’s antibody","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-13","type":"deal","source":"South China Morning Post","summary":"Novartis, SciNeuro deal offers hope for 55 million suffering from Alzheimer’s - South China Morning Post","headline":"Novartis, SciNeuro deal offers hope for 55 million suffering from Alzheimer’s","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPQzBST2dGb2FrRUF5SjZST01vbUgxa1E5c2V6MG0taUVDcUNvV3FMeld2V1N0N2p0Rk1TbFVNR3duZUE5d0dyMGhUU202OUhVTUY2dU56WS1Qb09aNFZabFJnY0tlaHVDRHR5OVEyTEltT29rOWV5N2Q3SkExdkw5UjZVZ2Zyb2FZR3o2VGszaE1ESFBrVmhoYm0yNUtNd0xRMGc?oc=5","date":"2026-01-12","type":"pipeline","source":"Fierce Biotech","summary":"Novartis pays SciNeuro $165M for ticket on another shuttle to brain - Fierce Biotech","headline":"Novartis pays SciNeuro $165M for ticket on another shuttle to brain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFB0Sno3ZFhkcEM4c2ROeVdRbVZ4Z1RlTW5SaDF5NmZKaHlPblBBbU1aS3ZiU0E2REFPYjVBMUsxTkdJOUs0eTcxVjJzOFEwZGlTUWMw?oc=5","date":"2026-01-12","type":"pipeline","source":"FirstWord Pharma","summary":"Novartis bets up to $1.7B on SciNeuro's brain shuttle in Alzheimer's push - FirstWord Pharma","headline":"Novartis bets up to $1.7B on SciNeuro's brain shuttle in Alzheimer's push","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNcFBma0x0TFpWOXlmTGx0MlYzbFlpcklXSTAwcEdyTUYxeUNCLWk3QVFCUFVObnE3dFExY0F1bmtTWGk3MFdjR1psTlhKSjA5UktIcThha3Z0alNJbUF4QWRmZVBJUEpEMnNqdV9RakRVQndkcDAtNVBwVXBiNXd1TjJWSzVZdGVwazFtdlo3RGs?oc=5","date":"2026-01-12","type":"pipeline","source":"BioSpace","summary":"Novartis Makes $1.5B+ Alzheimer’s Play With China’s SciNeuro - BioSpace","headline":"Novartis Makes $1.5B+ Alzheimer’s Play With China’s SciNeuro","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxNTzNQVFFXTlMxbk9tWkJNc1ZadU5EOTBKdVMtZVRqWlRoMXN1UHlqX05PblI4eFVSZEdOaUxWYXJkRHJyNmRZWXJNQmFHVUxkRkE1T0FRV3JONGtfOXRIazctWkNrZmREWXF5Q0tFN28yM040VDF3OWxkUnV0eFRKQWIzeTlIU2VMVnItZ0hfTWM0ZUYzTlVmdVdTc19xREZRQVVIT2lmb1ZuN19aYWNiczJCVFFZR3ItRXdZNzlmYmNOd1dTV3JQcVhqaDJTVDNzWW5ZeEthR1I5cUtiQ19RZXpXcFlKWlpNbDd4UC1zeHpRVGRNRk1DcWozTjloblJFSHM5TmdoSy1nWFZKVW5nNWlNdlJKWTFj?oc=5","date":"2026-01-12","type":"deal","source":"PR Newswire","summary":"SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzheimer's Disease - PR Newswire","headline":"SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzhe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNdzZZSFJjdXQ2a2hyQmVMYnRjWDNRN3lzTUNxMWo1bElWTnRzTmc2UUMycWdPLTktbWZpUzFfSFF5QjEycDRQSHpMRVdOM2hudHpSSXh4eC1wWkZERF92VEc5OWV3Ym9DWGpqOTJyclFXMkg2WmlVcjBzWkpPeE9yT2xhWk1pX1NZdjYxbzFiOFpkZnlCZHRBY3pRcDV0WTRXYTNJMUtLdDdRXzY3OUFDNGFqRmxseElLZ3R0Z2dPVS00MWhkWFl3Mg?oc=5","date":"2026-01-12","type":"deal","source":"Reuters","summary":"SciNeuro, Novartis sign $1.7 billion licensing deal to develop Alzheimer's drugs - Reuters","headline":"SciNeuro, Novartis sign $1.7 billion licensing deal to develop Alzheimer's drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxONXREajc3Yk43S2tLTkE0a2tvZFIzYnZlbmM4SmJXNEQ1VHlhRFpzak9zdUFXUHlQaHBqQkNqNWJNUjByejNpYWpvUWVSZE56NmRFdGFqSlZOYUh5NEJlNm1zeDM3VUUyTXlJRURpSXdxYVhDZmlBbUpkaWllNkQ4M2pVUjdOTy1wbTFXekN4aTVwQkwwTXlMV0ozMUJyZWFJZUFDNkFHNTRYZ0tlM0NyM1IzcUxiQ1N4eE5VTnZ0Tm9tSEFUTU9aeVB4Z1hvYkxy?oc=5","date":"2026-01-06","type":"pipeline","source":"BioBuzz","summary":"Maryland-based SciNeuro Closes $53M Raise to Advance Neurodegenerative Pipeline and Appoints New CFO - BioBuzz","headline":"Maryland-based SciNeuro Closes $53M Raise to Advance Neurodegenerative Pipeline and Appoints New CFO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygJBVV95cUxNT2txZUI0WjBiZ3gwdFowY0tCaHgzdk9jUENrQnlMSGVFM21nWXgyZl92a2xTektPRW9kVlc3bFZkbTltQ0VLZmdlVEJqNXhHa1Q4aUx0WF9odTdxN3JYY3phemtoQ2ZULTViOWJ4SmM5QjdCQ1M5M19QQjNhVTUtd3FHYWpOaUZJT3dVMWVkTzJCN0pMVVJGNTRZRUt2WWI2Q3JfM0ZlTkl6WHRnZGZpTDB1Rm9EczdUaWxSeU12NjAzTlNpYVVWZzFNM20wdkU4QTRJM21kNXE2RzJXWWV1LUttRHljTkxjYndUamVQaW1qZENMbmJVdnJQNGR5M25DbENZWE9oR1JwY21wWnJmQ1RqY2R1UmFOV3Q4VGtwLUJ5bHFwdm0tLWpIQU1KMmRybUpEemtNLVFPWkQ2MUJOd0lfWUdBaTU1NUE?oc=5","date":"2025-12-04","type":"pipeline","source":"PR Newswire","summary":"SciNeuro Pharmaceuticals Announces $53 Million Financing to Further Advance Pipeline of Therapies for Neurodegenerative Diseases and Appointment of Chief Financial Officer - PR Newswire","headline":"SciNeuro Pharmaceuticals Announces $53 Million Financing to Further Advance Pipeline of Therapies for Neurodegenerative ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOT1BpTjcyZk05S2JqNHIyS2tPdUZlWW01MFFzZEFIZENfcDZPcTdvRjRrUnFsMUtaV1NfN1FXY2laQnVZLVJ5aHpqMGhNTUEwLXFPY3pTMDVDQjF5YUJ5eW96QkVZaWEwVWY2Tnd4UmloMk11empiaUpEYTZUYlhmS3RYeGdTUk5XcUx3bmZuaVQ3eG5vLTg5NA?oc=5","date":"2025-12-04","type":"pipeline","source":"BioPharma Dive","summary":"An Arch-backed biotech raises $53M to fight neurodegeneration - BioPharma Dive","headline":"An Arch-backed biotech raises $53M to fight neurodegeneration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQa1VtS3NxX3BWQjlqX2NuQTZHWlZrRVlHV1pMMlhkTkFCQjVSNVRfWG1wREdtcTJtcjRtcktfMjZyNC1hTTRVVHZIaEh0VVBicmZkVTQxZFkyVlZJZ1lsMzU4MjhwX3lmN3pwQkdNUGNTTnJDc0VaZlFCZ3pOejc4TV9QQ2dZZjRfNFRaZnR3MGZQMjNPazEtUWYxM29fY1l3ZVhReFd5bnVjaGRD?oc=5","date":"2025-12-04","type":"pipeline","source":"Longevity.Technology","summary":"SciNeuro lands $53m to address the underlying biology of neurodegeneration - Longevity.Technology","headline":"SciNeuro lands $53m to address the underlying biology of neurodegeneration","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}